Interstitial Lung Diseases

European Respiratory Society Monograph, Vol. 46. 2009

ISBN: 978-1-904097-72-3

DOI: 10.1183/1025448x.ERM4609

Interstitial lung diseases represent an expanding field of respiratory medicine and pose important daily challenges for lung physicians. There have been tremendous advances in recent years in the understanding of the genetic basis and pathogenesis of a wide range of interstitial lung diseases. This book aims to highlight current challenges, open questions and international concerns, and to discuss a wide range of interstitial lung diseases in innovative contributions from experts from around the world.

The Guest Editors Eur Respir Mon; 2009: 46: vii
Preface Eur Respir Mon; 2009: 46: viii
Introduction Eur Respir Mon; 2009: 46: ix–x
Interstitial lung diseases today U. Costabel, T.E. King Jr Eur Respir Mon; 2009: 46: 1–3
Exercise testing in interstitial lung disease diagnosis and management M.K. Han, F.J. Martinez Eur Respir Mon; 2009: 46: 7–23
Diagnosing idiopathic interstitial pneumonias: utility of surgical lung biopsy S.K. Huang, J.L. Myers, K.R. Flaherty Eur Respir Mon; 2009: 46: 24–35
The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases P. Spagnolo, L. Richeldi, G. Raghu Eur Respir Mon; 2009: 46: 36–46
The role of biomarkers in management of interstitial lung disease: implications of biomarkers derived from type II pneumocytes T. Nukiwa Eur Respir Mon; 2009: 46: 47–66
Clinical trials in interstitial lung disease J. Behr, P.W. Noble Eur Respir Mon; 2009: 46: 67–84
Idiopathic interstitial pneumonias A. Ferreira, H.R. Collard Eur Respir Mon; 2009: 46: 87–111
Extrinsic allergic alveolitis C. Diego, P. Cullinan Eur Respir Mon; 2009: 46: 112–125
Sarcoidosis J.C. Grutters, M. Drent, J.M.M. van den Bosch Eur Respir Mon; 2009: 46: 126–154
Pulmonary Langerhans' cell histiocytosis S. Harari, A. Caminati Eur Respir Mon; 2009: 46: 155–175
Lymphangioleiomyomatosis D. Clements, W.Y.C. Chang, S.R. Johnson Eur Respir Mon; 2009: 46: 176–207
Pulmonary alveolar proteinosis B.C. Trapnell, K. Uchida Eur Respir Mon; 2009: 46: 208–224
Connective tissue disease-associated lung disorders A.L. Olson, K.K. Brown Eur Respir Mon; 2009: 46: 225–250
Pulmonary vasculitis: update on the management of ANCA-associated vasculitis U. Specks Eur Respir Mon; 2009: 46: 251–264
Occupational interstitial lung disease C.S. Glazer, L. Maier Eur Respir Mon; 2009: 46: 265–286
Drug-induced infiltrative lung disease V. Cottin, P. Bonniaud Eur Respir Mon; 2009: 46: 287–318
Paediatric interstitial lung disease A. Bush, A.G. Nicholson Eur Respir Mon; 2009: 46: 319–354
Interstitial lung diseases in a resource-limited setting: the case of India Z.F. Udwadia, T. Sen, S.K. Jindal Eur Respir Mon; 2009: 46: 357–374
Interstitial lung disease: specific issues in the Far East D.S. Kim, S. Nagai Eur Respir Mon; 2009: 46: 375–385
Clinical use of interstitial lung disease guidelines T. Leong, M. Conron Eur Respir Mon; 2009: 46: 386–395